Based on the intervention report and CEA parameters provided, I'll decompose GiveWell's water quality interventions analysis into investigation threads. Since the baseline AI output was not accessible, I'll proceed without that exclusion list, but will focus on areas that appear underexplored based on the report content.

## INVESTIGATION THREADS

### THREAD 1: External Validity of Mortality RCTs to Current Implementation Contexts

**SCOPE:** This thread investigates whether the five mortality RCTs that form the basis of GiveWell's 14% mortality reduction estimate (pooled ln(RR) = -0.146) remain valid for current program contexts, given changes in baseline mortality, water sources, sanitation infrastructure, and healthcare access since the trials were conducted.

**KEY PARAMETERS:** 
- External validity adjustment (ranges from 0.558 to 1.214 across programs)
- Pooled ln(RR) of -0.146
- Baseline under-5 mortality rates (0.0083-0.0134 across programs)

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** GiveWell applies program-specific external validity adjustments that vary by over 100% across programs. They acknowledge that baseline mortality has declined since the original trials.

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** Potential non-linear relationships between baseline mortality and treatment effect; interaction effects between improved water quality and concurrent health system improvements; changes in pathogen mix over time.

**DATA SOURCES TO EXAMINE:**
- Original five RCTs used in meta-analysis (specific citations needed)
- DHS/MICS surveys showing mortality and WASH trends in implementation countries
- Recent water quality studies in implementation areas
- WHO/UNICEF JMP data on water source improvements

**MATERIALITY THRESHOLD:** A 30% reduction in the pooled mortality effect (from 14% to 10%) would reduce cost-effectiveness by approximately 25-30%, potentially dropping some programs below funding thresholds.

**KNOWN CONCERNS ALREADY SURFACED:** GiveWell acknowledges uncertainty in external validity and applies adjustments, but specific mechanisms driving validity concerns are not detailed in the available report.

### THREAD 2: Cryptosporidium Prevalence and Chlorine-Resistant Pathogen Burden

**SCOPE:** This thread examines the proportion of diarrheal disease burden attributable to chlorine-resistant pathogens (particularly Cryptosporidium) in implementation areas and whether this has changed since the original RCTs.

**KEY PARAMETERS:**
- Implicit pathogen mix assumptions in the pooled mortality effect
- No explicit adjustment for chlorine-resistant pathogens in the model

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** The report explicitly acknowledges that chlorine has "limited effectiveness against the protozoan parasite Cryptosporidium, a common cause of diarrhea in children in low-income settings."

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** Quantitative adjustment for varying Cryptosporidium prevalence across settings; potential increases in chlorine-resistant pathogen burden over time; differential effectiveness by age given varying pathogen susceptibility.

**DATA SOURCES TO EXAMINE:**
- GEMS (Global Enteric Multicenter Study) data on pathogen-specific attributable fractions
- MAL-ED study data on age-specific pathogen burden
- Recent molecular diagnostic studies of diarrheal etiology in implementation countries
- Studies on chlorine effectiveness against specific pathogens at field-relevant doses

**MATERIALITY THRESHOLD:** If chlorine-resistant pathogens account for >25% of preventable diarrheal mortality in implementation areas, this could reduce program effectiveness by 20-30%, shifting cost-effectiveness below 6x cash for several programs.

**KNOWN CONCERNS ALREADY SURFACED:** Cryptosporidium resistance is acknowledged but not quantified.

### THREAD 3: Adherence Decay and Long-term Usage Patterns

**SCOPE:** This thread investigates whether the adherence and usage rates observed during relatively short RCT periods (typically 1-2 years) persist in scaled programs operating for 5+ years without intensive monitoring.

**KEY PARAMETERS:**
- Implicit adherence assumptions embedded in the mortality effect
- Cost per person treated (assumes certain coverage/usage rates)

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** The CEA includes program-specific costs that may reflect some operational realities, but adherence adjustments are not explicit in the parameter list.

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** Long-term adherence decay; seasonal variation in water source usage; competition from improving piped water access; behavioral fatigue with chlorination.

**DATA SOURCES TO EXAMINE:**
- Long-term follow-up studies of chlorination programs
- Dispensers for Safe Water monitoring data on usage rates over time
- Studies on factors affecting sustained adoption of water treatment
- Program administrative data on chlorine refill rates

**MATERIALITY THRESHOLD:** A 40% reduction in effective coverage due to adherence issues would reduce cost-effectiveness proportionally, potentially dropping programs below funding thresholds.

**KNOWN CONCERNS ALREADY SURFACED:** Not explicitly addressed in available materials.

### THREAD 4: Age-Specific Effect Heterogeneity and Mortality Concentration

**SCOPE:** This thread examines whether the mortality reduction is concentrated in specific age sub-groups within the under-5 category and whether the moral weights appropriately capture this concentration.

**KEY PARAMETERS:**
- Single under-5 mortality effect applied uniformly
- Moral weights for under-5 (108-112) vs over-5 (66-70)
- Adult mortality scaling factor (0.317-0.892)

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** Separate moral weights for under-5 and over-5 populations; an adult mortality scaling factor that reduces the assumed effect in older populations.

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** Potential concentration of effects in 6-24 month olds (peak diarrhea mortality age); different baseline immunity by age; varying water consumption patterns by age.

**DATA SOURCES TO EXAMINE:**
- Age-disaggregated data from the five mortality RCTs
- Studies on age-specific diarrhea mortality patterns
- Immunological studies on enteric pathogen exposure and immunity development
- Water consumption studies by age

**MATERIALITY THRESHOLD:** If 70% of the mortality effect is concentrated in ages 6-24 months (rather than distributed across under-5s), this could affect the moral weight calculation and reduce cost-effectiveness by 15-20%.

**KNOWN CONCERNS ALREADY SURFACED:** Age distinctions are made between under-5 and over-5, but not within the under-5 group.

### THREAD 5: Implementation Fidelity at Scale

**SCOPE:** This thread investigates whether chlorine dispensers and in-line chlorination systems as implemented at scale achieve the water quality improvements assumed in the model, including proper dosing, maintenance, and supply chain reliability.

**KEY PARAMETERS:**
- Cost per person (implicitly assumes certain implementation quality)
- No explicit implementation quality adjustment

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** Program-specific costs that may reflect some operational realities.

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** Chlorine stockouts; improper dosing due to varying source water turbidity; maintenance delays; seasonal variation in water volume affecting concentration.

**DATA SOURCES TO EXAMINE:**
- Program monitoring data on chlorine levels at point of use
- Supply chain reliability data from implementers
- Water quality testing results from scaled programs
- Maintenance logs and stockout reports

**MATERIALITY THRESHOLD:** If 30% of water points have inadequate chlorination (due to stockouts, mechanical issues, or improper dosing), this would reduce effectiveness proportionally and could drop cost-effectiveness below thresholds.

**KNOWN CONCERNS ALREADY SURFACED:** Not explicitly addressed in available materials.

### THREAD 6: Plausibility Cap Mechanism and Binding Constraints

**SCOPE:** This thread examines the methodology behind the plausibility caps (0.056-0.109) and why they bind for 3 of 4 programs, potentially indicating that the model's uncapped estimates strain credibility.

**KEY PARAMETERS:**
- Plausibility caps (binding for ILC Kenya at 0.109, DSW B at 0.056, DSW D at 0.109)
- Parameters that drive estimates above caps

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** Explicit plausibility caps that constrain the mortality reduction estimates.

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** The report doesn't explain why uncapped estimates exceed plausibility thresholds for most programs, suggesting potential model misspecification.

**DATA SOURCES TO EXAMINE:**
- GiveWell's methodology documentation on plausibility caps
- Comparable all-cause mortality reductions from other child health interventions
- Biological plausibility constraints on diarrhea's contribution to all-cause mortality

**MATERIALITY THRESHOLD:** This is a structural issue - if the caps are set too high, all programs may be overestimated by 20-50%.

**KNOWN CONCERNS ALREADY SURFACED:** Caps are applied but rationale is not transparent.

### THREAD 7: Mills-Reincke Phenomenon and Indirect Effects

**SCOPE:** This thread investigates the use of a Mills-Reincke multiplier of 3.74 to account for indirect mortality effects beyond diarrhea and whether this historical phenomenon applies to modern low-income settings.

**KEY PARAMETERS:**
- Mills-Reincke multiplier: 3.744
- Adjusted diarrhea RR: 0.805

**WHAT GIVEWELL ALREADY ACCOUNTS FOR:** An explicit multiplier to capture indirect effects based on historical water infrastructure improvements in developed countries.

**WHAT GIVEWELL DOES NOT ACCOUNT FOR:** Whether the historical Mills-Reincke relationship holds in settings with different disease burdens, health systems, and causes of death.

**DATA SOURCES TO EXAMINE:**
- Original Mills-Reincke studies and their contexts
- Modern studies on water quality and non-diarrheal mortality
- Pathway analyses for water-mortality relationships beyond enterics
- Studies from similar LMIC contexts rather than historical developed country data

**MATERIALITY THRESHOLD:** If the true multiplier is 2.0 instead of 3.74, this would reduce cost-effectiveness by approximately 30-40%.

**KNOWN CONCERNS ALREADY SURFACED:** The multiplier is applied but its validity for current contexts is not examined.

## DEPENDENCY MAP

- **Thread 1 & 4 interact:** Age-specific effects influence external validity assessments
- **Thread 2 & 7 interact:** Pathogen mix affects the plausibility of indirect effects
- **Thread 3 & 5 interact:** Implementation quality affects adherence and vice versa
- **Thread 6 depends on all others:** Plausibility caps may need revision based on findings from other threads

## RECOMMENDED SEQUENCING

1. **First: Thread 6** - Understanding the plausibility cap methodology provides context for interpreting all other findings
2. **Second: Thread 1** - External validity is the highest-leverage parameter and affects interpretation of all RCT evidence
3. **Third: Threads 2 & 7 in parallel** - Both examine the biological mechanisms underlying the mortality effect
4. **Fourth: Threads 3 & 5 in parallel** - Implementation issues that could be investigated through field data
5. **Last: Thread 4** - Age effects are important but may be harder to definitively resolve